Related Experiment Videos
Soft-tissue venous malformations in children: percutaneous sclerotherapy with Ethibloc
J M Dubois1, G H Sebag, Y De Prost
1Department of Pediatric Radiology, Hôpital des Enfants Malades, Paris, France.
Insights
Percutaneous Ethibloc injections effectively treated soft-tissue venous malformations (VMs) in children. This minimally invasive approach achieved good or excellent results in 74% of cases with few side effects.
Area of Science:
- Vascular Surgery
- Pediatric Surgery
- Interventional Radiology
Background:
- Soft-tissue venous malformations (VMs) are common congenital vascular anomalies in children.
- Traditional treatments for VMs can be invasive and associated with significant morbidity.
- There is a need for effective, minimally invasive treatment options for pediatric VMs.
Purpose of the Study:
- To evaluate the efficacy and safety of percutaneous Ethibloc injection for treating soft-tissue venous malformations in children.
- To assess the technique, outcomes, side effects, and complications associated with this novel fibrosing agent.
Main Methods:
- Thirty-eight children with soft-tissue VMs underwent percutaneous injection of Ethibloc.
- The procedure involved direct puncture of the malformation for evaluation and injection.
- Treatment was performed either as a standalone procedure or in conjunction with surgery.
Main Results:
- Good or excellent results were achieved in 74% of the treated cases.
- Complete cure was observed in 50% of the patients.
- The procedure was associated with minimal side effects and no major complications.
Conclusions:
- Percutaneous Ethibloc injection is a safe and effective treatment for pediatric soft-tissue venous malformations.
- This minimally invasive technique offers a high success rate with a favorable safety profile.
- Ethibloc represents a promising new therapeutic option for managing VMs in children.
Abstract:
Thirty-eight children with soft-tissue venous malformations (VMs) were treated with percutaneous injection of a new fibrosing agent (Ethibloc). The technique, results, side effects, and complications are detailed. Direct puncture of the VM allows evaluation of the draining venous system and direct injection of Ethibloc. This procedure alone or associated with surgery led to achievement of good or excellent results in 74% of the cases (complete cure in 50%), with minimal side effects and no major complications.